Report Viewer
NINDS CDE Notice of Copyright
Treatment Satisfaction Questionnaire for Medication
Treatment Satisfaction Questionnaire for Medication
| Availability |
IQVIA, Inc., holds the copyright for the TSQM. Any user of the TSQM must obtain permission for use from Quintiles. There is a per-use fee associated with the TSQM: Please Click For Treatment Satisfaction Questionnaire for Medication
|
| Classification |
Supplemental for Multiple Sclerosis (MS)
|
| Short Description of Instrument |
Construct measured: Quality of Life/Self-reported Patient Satisfaction
Generic vs. disease specific: Generic
Means of administration: Self-administered
Intended respondent: Patient
#of items:9
# of subscales and names of sub-scales:3 – Effectiveness, Convenience, Global satisfaction
# of items per sub-scale:3
|
| Comments/Special Instructions |
Scoring: Domain scores range from 0-100. Higher scores mean higher satisfaction on each domain.
Background: Although numerous disease-specific measures of patients' treatment satisfaction for medication (TS-M) have been reported in the literature, less attention has been paid to developing a more general measure of TS-M--one that would permit comparisons across medication types and patient conditions. To fill this gap, the TSQM was developed. The abbreviated 9 item TSQM (TSQM-9, developed in 2008) is derived from the TSQM Version 1.4 (developed in 2004) but without the five items of the side effects domain.
|
| Rationale/Justification |
Strengths/ Weaknesses: The use of TSQM-9 over the earlier versions of the TSQM is not recommended in clinical studies where there is no possibility of the side effects domains interfering with study objectives and where the outcome of investigational drugs are being studied.
Psychometric Properties: High test-retest reliability
Administration: 5-10 minutes
|
| References |
Bharmal M, Payne K, Atkinson MJ, Desrosiers M-P, Morisky DE, Gemmen E. Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications. Health and Quality of Life Outcomes 2009, 7:36 doi:10.1186/1477-7525-7-36.
Document last updated March 2018
|